Lannett Company Inc. recalls Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc.,…
- Recall date
- October 10, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0096-2026
- FDA classification
- Class II
- Brand / firm
- Lannett Company Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46
Get recall alerts
Free email alert whenever Lannett Company Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lannett Company Inc.